<DOC>
	<DOC>NCT01723124</DOC>
	<brief_summary>The purpose of this research is to evaluate whether repeating a screening Molecular Breast Imaging (MBI) study two years after an initial screening MBI study further improves breast cancer detection in women with dense breast tissue.</brief_summary>
	<brief_title>Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Radiopharmaceuticals</mesh_term>
	<criteria>Past prior screening mammogram within the previous 1124 months interpreted as heterogeneously dense or extremely dense and negative or benign [Breast Imaging Reporting and Data System (BIRADS) Category 1 or 2] Subjects will be excluded if they: Are unable to understand and sign the consent form Are pregnant or lactating Are physically unable to sit upright and still for 40 minutes Have selfreported signs or symptoms that may suggest breast cancer (palpable mass, bloody nipple discharge, axillary mass, etc.) Have had needle biopsy within 3 months, or breast surgery or radiation within 1 year prior to the study Are currently receiving chemotherapy or tamoxifen, raloxifene, or an aromatase inhibitor for adjuvant therapy or chemoprevention Have undergone bilateral mastectomy Have had a prior MBI within 20 months of scheduled study MBI.</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Dense breast tissue</keyword>
	<keyword>breast cancer screening</keyword>
	<keyword>molecular breast imaging</keyword>
	<keyword>breast cancer</keyword>
	<keyword>breast</keyword>
</DOC>